Generate a tailored SOP for Dr. Rebecca Lehmann. Improve your application with a focused, well-structured draft.
Rebecca Lehmann is a Conjoint Lecturer and postdoctoral researcher in the Brain Tumour group at the Children's Cancer Institute. She graduated with a Bachelor of Biomedical Science from the University of Adelaide in 2013, achieving First Class Honours, and completed her PhD at the same institution in 2019. During her PhD candidature, she investigated the mechanisms underlying severe neurological pathologies in pediatric neurodegenerative diseases, specifically focusing on Mucopolysaccharidosis. Post-PhD, Rebecca's research has centered on identifying new treatments for children with Diffuse Midline Glioma, a notoriously hard-to-treat brain tumor. She is engaged in multi-faceted projects aimed at developing effective therapies for drug-resistant variations of this childhood cancer. Her commitment to advancing pediatric oncology is reflected in several prestigious awards, including honors from the Australian Society of Medical Research and the Children’s Cancer Institute. In addition to her research, Rebecca is actively involved in teaching and supervising honors students with a focus on innovative therapeutic approaches in pediatric brain tumors.
Children's Cancer Institute • Sydney, Australia
Conducts research on pediatric brain tumors, focusing on treatment resistant Diffuse Midline Glioma.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.